Clinical Trials Directory

Trials / Completed

CompletedNCT04641130

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

Validation and Reproducibility Study of the ALYATEC Allergen Exposure Chamber by Determining the Concentration of Birch Pollen Allergen Inducing Conjunctivitis in Subjects Allergic to Birch Pollen.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Alyatec · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a single center open study designed to determine the concentration of airborne birch pollen inducing an allergic conjunctivitis response in individuals allergic to birch pollen, during allergen exposures in the Alyatec environmental exposure chamber (EEC).

Conditions

Interventions

TypeNameDescription
OTHERExposure to birch pollen in EECPatients are exposed to airborne birch pollen allergen. The duration of each exposure is 4h maximum.

Timeline

Start date
2017-07-13
Primary completion
2017-08-30
Completion
2017-09-11
First posted
2020-11-23
Last updated
2020-12-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04641130. Inclusion in this directory is not an endorsement.

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC (NCT04641130) · Clinical Trials Directory